Graham Capital Management, L.P. Bio Xcel Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$9.03 - $21.55 $387,513 - $924,796
-42,914 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$15.0 - $22.83 $450,135 - $685,105
30,009 Added 232.54%
42,914 $897,000
Q4 2021

Feb 14, 2022
BUY
$20.12 - $35.09 $259,648 - $452,836
12,905 New
12,905 $262,000

Others Institutions Holding BTAI

# of Institutions
53
Shares Held
3.13M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $9.53M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email